Functional studies have demonstrated that DDX11-AS1 interacts with RNA-binding protein heterogeneous nuclear ribonucleoprotein C (HNRNPC), promoting Wnt/β-catenin and AKT pathways, as well as epithelial-mesenchymal transition, thereby facilitating glioma cell proliferation [35]. Here, DDX11 is linked to central nervous system cancer.